Tumor-derived PD-L1 is capable of immunosuppression, but we suppose that stromal-derived PD-L1 plays a more important role in CD8+ T cell inhibition because sPD-L1 has direct contact with CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.